Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Accounts Payables data on file, last reported at $372.0 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 12.73% year-over-year to $372.0 million; the trailing twelve-month figure through Mar 2026 stood at $372.0 million (up 12.73% YoY), and the FY2025 full-year result was $368.0 million, up 24.32% from the prior year.
• Accounts Payables climbed to $372.0 million in Q1 2026, from $368.0 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $402.0 million in Q1 2022 to a low of $259.0 million in Q3 2024.
• A 5-year average of $339.2 million and a median of $352.0 million in 2025 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables tumbled 30.77% in 2023 and jumped 35.91% in 2025, its largest moves.
• Tracing ELAN's Accounts Payables over 5 years: stood at $390.0 million in 2022, then plunged by 30.77% to $270.0 million in 2023, then climbed by 9.63% to $296.0 million in 2024, then advanced by 24.32% to $368.0 million in 2025, then climbed by 1.09% to $372.0 million in 2026.
• Business Quant data shows ELAN's Accounts Payables at $372.0 million in Q1 2026, $368.0 million in Q4 2025, and $352.0 million in Q3 2025.